ONdrugDelivery gives readers the latest industry news, insights, and information on ideas, technologies, services, and products being developed in the global pharma and biopharma sectors.
With more biologics losing their patent exclusivity, the market is opening up for biosimilars. As a result, there will be more competition, which usually leads to lower costs for these treatments. So, is there room for innovation? Find out more on pages 24-25.